Aspen to Buy Anesthetics From AstraZeneca for $520 Million

  • South African drugmaker will also make sales-related payments
  • Deal comes after Aspen secured 3 billion euros in funding

Aspen Pharmacare Holdings Ltd. agreed to buy anesthetics medicines from AstraZeneca Plc for at least $520 million, the first acquisition by Africa’s largest generic-drugs maker since securing new funding.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.